Close Menu

NEW YORK (GenomeWeb) – Sophia Genetics announced today that it has closed a $15 million Series C financing round led by Belgian billionaire Marc Coucke, the founder of Omega Pharma.

The Swiss genetics company will use the funds to add to its line of genomic tests and continue expanding its market, it said in a statement. Sophia added that it has seen a 400 percent growth rate in 2015, led by its analytics platform, Sophia Data Driven Medicine.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.

Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.

Slate's Jane Hu compares some at-home genetic tests to astrology.

In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.